{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:25:52Z","timestamp":1791271552438,"version":"4.1.0"},"reference-count":266,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.bbapap.2004.10.005","type":"journal-article","created":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T18:28:44Z","timestamp":1099592924000},"page":"1-25","source":"Crossref","is-referenced-by-count":191,"title":["The SH2 domain: versatile signaling module and pharmaceutical target"],"prefix":"10.1016","volume":"1747","author":[{"given":"Kazuya","family":"Machida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2004.10.005_bib1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1708916","article-title":"SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins","volume":"252","author":"Koch","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0962-8924(01)02154-7","article-title":"SH2 domains, interaction modules and cellular wiring","volume":"11","author":"Pawson","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0092-8674(00)80276-7","article-title":"SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in Dictyostelium","volume":"89","author":"Kawata","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1126\/science.1083653","article-title":"Assembly of cell regulatory systems through protein interaction domains","volume":"300","author":"Pawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(01)03295-1","article-title":"Normalization of nomenclature for peptide motifs as ligands of modular protein domains","volume":"513","author":"Aasland","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0092-8674(93)90404-E","article-title":"SH2 domains recognize specific phosphopeptide sequences","volume":"72","author":"Songyang","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib7","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/MCB.14.4.2777","article-title":"Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps\/fes, GRB-2, HCP, SHC, Syk, and Vav","volume":"14","author":"Songyang","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/373573a0","article-title":"Protein modules and signalling networks","volume":"373","author":"Pawson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","article-title":"Specificity in signal transduction. From phosphotyrosine-SH2 domain interactions to complex cellular systems","volume":"116","author":"Pawson","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib10","doi-asserted-by":"crossref","first-page":"RE12","DOI":"10.1126\/stke.2003.191.re12","article-title":"SH2 and PTB domains in tyrosine kinase signaling","volume":"2003","author":"Schlessinger","year":"2003","journal-title":"Sci. STKE"},{"key":"10.1016\/j.bbapap.2004.10.005_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrm759","article-title":"Phosphotyrosine-binding domains in signal transduction","volume":"3","author":"Yaffe","year":"2002","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib12","doi-asserted-by":"crossref","first-page":"11987","DOI":"10.1074\/jbc.273.20.11987","article-title":"Autoregulatory mechanisms in protein-tyrosine kinases","volume":"273","author":"Hubbard","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib13","doi-asserted-by":"crossref","first-page":"21478","DOI":"10.1016\/S0021-9258(20)80562-6","article-title":"Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor","volume":"268","author":"Lechleider","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0969-2126(98)00027-6","article-title":"Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2","volume":"6","author":"Barford","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.bbapap.2004.10.005_bib15","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1074\/jbc.270.18.10498","article-title":"Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE","volume":"270","author":"Shiue","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib16","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1992.tb05426.x","article-title":"Phosphatidylinositol 3\u2032-kinase is activated by association with IRS-1 during insulin stimulation","volume":"11","author":"Backer","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib17","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1074\/jbc.270.8.3662","article-title":"Regulation of phosphatidylinositol 3\u2032-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit","volume":"270","author":"Rordorf-Nikolic","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib18","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1128\/MCB.15.6.3171","article-title":"Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins","volume":"15","author":"Neumeister","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib19","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1074\/jbc.273.8.4465","article-title":"Activation of phospholipase C-gamma by phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Bae","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/1074-5521(95)90183-3","article-title":"Tyrosine kinases: modular signaling enzymes with tunable specificities","volume":"2","author":"Shokat","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0079-6107(98)00045-5","article-title":"Recognition and regulation of primary-sequence motifs by signaling modular domains","volume":"71","author":"Songyang","year":"1999","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0960-9822(95)00060-1","article-title":"Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases","volume":"5","author":"Mayer","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.biophys.26.1.259","article-title":"Modular peptide recognition domains in eukaryotic signaling","volume":"26","author":"Kuriyan","year":"1997","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.bbapap.2004.10.005_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0092-8674(93)90405-F","article-title":"Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms","volume":"72","author":"Waksman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/362087a0","article-title":"Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck","volume":"362","author":"Eck","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsb0796-586","article-title":"Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode","volume":"3","author":"Rahuel","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-3233(02)61005-8","article-title":"Molecular recognition by SH2 domains","volume":"61","author":"Bradshaw","year":"2002","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib28","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1073\/pnas.92.8.3199","article-title":"Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal","volume":"92","author":"Ladbury","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib29","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1021\/bi973147k","article-title":"Probing the \u201ctwo-pronged plug two-holed socket\u201d model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study","volume":"37","author":"Bradshaw","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib30","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/bi00064a001","article-title":"Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide\/SH2 domain binding","volume":"32","author":"Piccione","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/jmbi.1999.3190","article-title":"Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase","volume":"293","author":"Bradshaw","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib32","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1073\/pnas.142224499","article-title":"Specificity and affinity motifs for Grb2 SH2\u2013ligand interactions","volume":"99","author":"Kessels","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib33","doi-asserted-by":"crossref","first-page":"26029","DOI":"10.1074\/jbc.270.44.26029","article-title":"A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group I SH2 domains","volume":"270","author":"Songyang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/369502a0","article-title":"SH2 domain specificity and activity modified by a single residue","volume":"369","author":"Marengere","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1097-2765(00)80269-5","article-title":"Structural basis for specificity switching of the Src SH2 domain","volume":"5","author":"Kimber","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib36","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1021\/bi962642y","article-title":"Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands","volume":"36","author":"Gay","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(91)90148-R","article-title":"BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner","volume":"66","author":"Pendergast","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib38","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/MCB.12.11.5087","article-title":"A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction","volume":"12","author":"Muller","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib39","doi-asserted-by":"crossref","first-page":"33009","DOI":"10.1016\/S0021-9258(20)30091-0","article-title":"A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand","volume":"269","author":"Malek","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib40","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1074\/jbc.271.12.6952","article-title":"p150TSP, a conserved nuclear phosphoprotein that contains multiple tetratricopeptide repeats and binds specifically to SH2 domains","volume":"271","author":"Malek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0092-8674(95)90195-7","article-title":"Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins","volume":"83","author":"Rameh","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib43","doi-asserted-by":"crossref","first-page":"24094","DOI":"10.1074\/jbc.274.34.24094","article-title":"mGrb10 interacts with Nedd4","volume":"274","author":"Morrione","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib44","doi-asserted-by":"crossref","first-page":"11918","DOI":"10.1074\/jbc.M111816200","article-title":"Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7","volume":"277","author":"Pero","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib45","doi-asserted-by":"crossref","first-page":"42596","DOI":"10.1074\/jbc.M305817200","article-title":"An SH2 domain-dependent, Phosphotyrosine-independent interaction between Vav1, and the Mer receptor tyrosine kinase: a mechanism for localizing GEF action","volume":"278","author":"Mahajan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1074\/mcp.M300131-MCP200","article-title":"Identification of the linker-SH2 domain of STAT as the origin of the SH2 domain using two dimensional structural alignment","volume":"3","author":"Gao","year":"2004","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.bbapap.2004.10.005_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0968-0004(93)90006-9","article-title":"A yeast SH2 domain","volume":"18","author":"Maclennan","year":"1993","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbapap.2004.10.005_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tplants.2004.02.001","article-title":"SH2 domains in plants imply new signalling scenarios","volume":"9","author":"Williams","year":"2004","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.bbapap.2004.10.005_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1074\/jbc.273.2.729","article-title":"Tandem SH2 domains confer high specificity in tyrosine kinase signaling","volume":"273","author":"Ottinger","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib50","doi-asserted-by":"crossref","first-page":"26738","DOI":"10.1074\/jbc.270.45.26738","article-title":"Enhanced affinities and specificities of consolidated ligands for the Src homology (SH) 3 and SH2 domains of Abelson protein-tyrosine kinase","volume":"270","author":"Cowburn","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib51","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1074\/jbc.271.15.8959","article-title":"Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase","volume":"271","author":"Nakamoto","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib52","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1101\/gad.10.11.1341","article-title":"Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel, p130cas-related protein, Sin","volume":"10","author":"Alexandropoulos","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbapap.2004.10.005_bib53","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2004.10.005_bib54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(91)90127-G","article-title":"Methods of detection of new families with X-linked lymphoproliferative disease","volume":"51","author":"Purtilo","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bbapap.2004.10.005_bib55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbapap.2004.10.005_bib57","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib58","doi-asserted-by":"crossref","first-page":"36809","DOI":"10.1074\/jbc.M101305200","article-title":"Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients","volume":"276","author":"Morra","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1097-2765(00)80206-3","article-title":"Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition","volume":"4","author":"Poy","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0960-9822(00)80080-9","article-title":"Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP\/SH2D1A","volume":"9","author":"Li","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/emboj\/21.3.314","article-title":"A \u201cthree-pronged\u201d binding mechanism for the SAP\/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome","volume":"21","author":"Hwang","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib62","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1093\/emboj\/20.21.5840","article-title":"Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells","volume":"20","author":"Morra","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-065X.2000.17819.x","article-title":"X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein","volume":"178","author":"Schuster","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbapap.2004.10.005_bib64","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.4049\/jimmunol.163.11.5860","article-title":"Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells","volume":"163","author":"Castro","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib65","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/intimm\/12.12.1749","article-title":"Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4","volume":"12","author":"Sayos","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib66","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.4049\/jimmunol.166.9.5480","article-title":"CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A","volume":"166","author":"Shlapatska","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib67","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1074\/jbc.M206649200","article-title":"Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP\/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/90615","article-title":"Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product","volume":"2","author":"Latour","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib69","doi-asserted-by":"crossref","first-page":"PE8","DOI":"10.1126\/stke.2002.120.pe8","article-title":"The SAP family: a new class of adaptor-like molecules that regulates immune cell functions","volume":"2002","author":"Veillette","year":"2002","journal-title":"Sci. STKE"},{"key":"10.1016\/j.bbapap.2004.10.005_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ncb920","article-title":"SAP couples Fyn to SLAM immune receptors","volume":"5","author":"Chan","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ncb919","article-title":"Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation","volume":"5","author":"Latour","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib72","doi-asserted-by":"crossref","first-page":"14053","DOI":"10.1073\/pnas.212518799","article-title":"Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide","volume":"99","author":"Donaldson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/intimm\/dxh074","article-title":"SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9","volume":"16","author":"Simarro","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib74","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1600-065X.2003.00023.x","article-title":"Molecular and immunological basis of X-linked lymphoproliferative disease","volume":"192","author":"Latour","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbapap.2004.10.005_bib75","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and Epstein\u2013Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2004.10.005_bib76","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1128\/MCB.14.10.6674","article-title":"Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation","volume":"14","author":"Noguchi","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni0103-19","article-title":"The dual-function CD150 receptor subfamily: the viral attraction","volume":"4","author":"Sidorenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0952-7915(03)00041-4","article-title":"The SLAM family of immune-cell receptors","volume":"15","author":"Veillette","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib79","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1202","article-title":"The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease","volume":"3","author":"Engel","year":"2003","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib80","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1128\/MCB.24.12.5144-5156.2004","article-title":"Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors","volume":"24","author":"Chen","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib81","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.4049\/jimmunol.158.9.4036","article-title":"Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production","volume":"158","author":"Aversa","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib82","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ni0901-823","article-title":"SAP controls T cell responses to virus and terminal differentiation of TH2 cells","volume":"2","author":"Wu","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib83","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1073\/pnas.131193098","article-title":"Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/SAP","volume":"98","author":"Czar","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib84","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.20031835","article-title":"The Cell Surface Receptor SLAM Controls T Cell and Macrophage Functions","volume":"199","author":"Wang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbapap.2004.10.005_bib85","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2003-09-3359","article-title":"SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease","volume":"103","author":"Sharifi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2004.10.005_bib86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/421276","article-title":"Analysis of immune activation and clinical events in acute infectious mononucleosis","volume":"190","author":"Williams","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbapap.2004.10.005_bib87","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4049\/jimmunol.172.2.1177","article-title":"Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis","volume":"172","author":"Pasquinelli","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib88","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.86.4.1168","article-title":"3rd, v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas","volume":"86","author":"Langdon","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib89","doi-asserted-by":"crossref","first-page":"22921","DOI":"10.1016\/S0021-9258(17)31595-8","article-title":"The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor","volume":"269","author":"Donovan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib90","doi-asserted-by":"crossref","first-page":"21468","DOI":"10.1074\/jbc.270.37.21468","article-title":"Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia","volume":"270","author":"de Jong","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib91","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1074\/jbc.270.32.19141","article-title":"The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase","volume":"270","author":"Fukazawa","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib92","doi-asserted-by":"crossref","first-page":"18260","DOI":"10.1074\/jbc.270.31.18260","article-title":"Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl","volume":"270","author":"Hartley","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib93","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1091\/mbc.11.11.4019","article-title":"Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation","volume":"11","author":"Yoon","year":"1995","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib94","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/genetics\/139.4.1553","article-title":"sli-1, a negative regulator of let-23-mediated signaling in C. elegans","volume":"139","author":"Jongeward","year":"1995","journal-title":"Genetics"},{"key":"10.1016\/j.bbapap.2004.10.005_bib95","doi-asserted-by":"crossref","first-page":"20242","DOI":"10.1074\/jbc.270.35.20242","article-title":"Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation","volume":"270","author":"Galisteo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib96","doi-asserted-by":"crossref","first-page":"24063","DOI":"10.1074\/jbc.271.39.24063","article-title":"A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells","volume":"271","author":"Lupher","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.286.5438.309","article-title":"The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase","volume":"286","author":"Joazeiro","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib98","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1097-2765(00)80231-2","article-title":"Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl\/Sli-1","volume":"4","author":"Levkowitz","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib99","doi-asserted-by":"crossref","first-page":"31707","DOI":"10.1074\/jbc.274.44.31707","article-title":"Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7","volume":"274","author":"Yokouchi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib100","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.95.14.7927","article-title":"The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha","volume":"95","author":"Miyake","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib101","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1101\/gad.12.23.3663","article-title":"c-Cbl\/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor","volume":"12","author":"Levkowitz","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbapap.2004.10.005_bib102","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/emboj\/18.13.3616","article-title":"The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation","volume":"18","author":"Lee","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib103","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1126\/science.276.5311.418","article-title":"The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase","volume":"276","author":"Ota","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib104","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1074\/jbc.275.1.414","article-title":"The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase","volume":"275","author":"Ota","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1097-2765(01)00378-1","article-title":"Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein","volume":"8","author":"Peschard","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/18050","article-title":"Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase","volume":"398","author":"Meng","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib107","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/sj.onc.1201193","article-title":"EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene","volume":"14","author":"Thien","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2004.10.005_bib108","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1074\/jbc.274.23.16619","article-title":"Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain","volume":"274","author":"Miyake","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib109","doi-asserted-by":"crossref","first-page":"33140","DOI":"10.1074\/jbc.272.52.33140","article-title":"The Cbl phosphotyrosine-binding domain selects a D(N\/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70","volume":"272","author":"Lupher","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib110","doi-asserted-by":"crossref","first-page":"13251","DOI":"10.1021\/bi0014397","article-title":"Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library","volume":"39","author":"Beebe","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib111","doi-asserted-by":"crossref","first-page":"11747","DOI":"10.1021\/bi960571x","article-title":"Characterization of SH2\u2013ligand interactions via library affinity selection with mass spectrometric detection","volume":"35","author":"Kelly","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib112","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1389203023380594","article-title":"Probing the phosphopeptide specificities of protein tyrosine phosphatases, SH2 and PTB domains with combinatorial library methods","volume":"3","author":"Vetter","year":"2002","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbapap.2004.10.005_bib113","doi-asserted-by":"crossref","first-page":"29565","DOI":"10.1074\/jbc.M403954200","article-title":"A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl\/Cbl-b TKB domain binding site required for suppression of oncogenic activation","volume":"279","author":"Peschard","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib114","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1038\/sj.onc.1204781","article-title":"Beyond the RING: CBL proteins as multivalent adapters","volume":"20","author":"Tsygankov","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2004.10.005_bib115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0092-8674(00)00057-X","article-title":"Structure of a c-Cbl\u2013UbcH7 complex: RING domain function in ubiquitin\u2013protein ligases","volume":"102","author":"Zheng","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib116","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1002\/j.1460-2075.1994.tb06773.x","article-title":"Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene","volume":"13","author":"Andoniou","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib117","doi-asserted-by":"crossref","first-page":"35185","DOI":"10.1074\/jbc.M102219200","article-title":"Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins","volume":"276","author":"Yokouchi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib118","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1083\/jcb.152.1.181","article-title":"Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility","volume":"152","author":"Sanjay","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib119","doi-asserted-by":"crossref","first-page":"28017","DOI":"10.1074\/jbc.M404114200","article-title":"Regulation of ubiquitin protein-ligase activity in c-Cbl by phosphorylation-induced conformational change, and constitutive activation by tyrosine to glutamate point mutations","volume":"279","author":"Kassenbrock","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib120","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1349-7006.1995.tb03303.x","article-title":"c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts","volume":"86","author":"Odai","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib121","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.4049\/jimmunol.164.9.4616","article-title":"The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells","volume":"164","author":"Rao","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib122","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1128\/MCB.17.8.4597","article-title":"Phosphotyrosine binding domain-dependent up-regulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity","volume":"17","author":"Bonita","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib123","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/sj.onc.1201468","article-title":"Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl","volume":"15","author":"Thien","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2004.10.005_bib124","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1097-2765(01)00183-6","article-title":"RING finger mutations that abolish c-Cbl-directed polyubiquitination and down-regulation of the EGF receptor are insufficient for cell transformation","volume":"7","author":"Thien","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1535-6108(03)00136-3","article-title":"Escape from Cbl-mediated down-regulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases","volume":"3","author":"Peschard","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib126","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib127","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/1074-7613(95)90012-8","article-title":"Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process","volume":"2","author":"Greenlund","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.bbapap.2004.10.005_bib128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0952-7915(98)80165-9","article-title":"JAK\/STAT signaling by cytokine receptors","volume":"10","author":"Liu","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-5699(94)90075-2","article-title":"Hormones, peripherally activated prohormones and regulation of the Th1\/Th2 balance","volume":"15","author":"Rook","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.bbapap.2004.10.005_bib130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The Role of Suppressors of Cytokine Signaling (SOCS) Proteins in Regulation of the Immune Response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib131","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1002\/j.1460-2075.1996.tb00754.x","article-title":"The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor","volume":"15","author":"Strous","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib132","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1073\/pnas.95.19.11330","article-title":"The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation","volume":"95","author":"Huber","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib133","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1074\/jbc.272.13.8739","article-title":"Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling","volume":"272","author":"Ueno","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib134","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/MCB.15.12.7050","article-title":"Differential regulation of the alpha\/beta interferon-stimulated Jak\/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1","volume":"15","author":"David","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib135","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1126\/science.278.5344.1803","article-title":"Specific inhibition of Stat3 signal transduction by PIAS3","volume":"278","author":"Chung","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib136","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jlb.63.6.665","article-title":"The SOCS proteins: a new family of negative regulators of signal transduction","volume":"63","author":"Nicholson","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib137","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","article-title":"Suppressors of cytokine signalling (SOCS) in the immune system","volume":"2","author":"Alexander","year":"2002","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib138","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1053\/gast.2002.37068","article-title":"Suppressors of cytokine signaling: relevance to gastrointestinal function and disease","volume":"123","author":"Greenhalgh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbapap.2004.10.005_bib139","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/j.1460-2075.1995.tb07281.x","article-title":"A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors","volume":"14","author":"Yoshimura","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib140","doi-asserted-by":"crossref","first-page":"28185","DOI":"10.1074\/jbc.273.43.28185","article-title":"Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein","volume":"273","author":"Verdier","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib141","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib142","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/43213","article-title":"A new protein containing an SH2 domain that inhibits JAK kinases","volume":"387","author":"Endo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib143","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/43219","article-title":"Structure and function of a new STAT-induced STAT inhibitor","volume":"387","author":"Naka","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib144","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0968-0004(02)02085-6","article-title":"The SOCS box: a tale of destruction and degradation","volume":"27","author":"Kile","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbapap.2004.10.005_bib145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1997.7080","article-title":"Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3","volume":"237","author":"Minamoto","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib146","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/bbrc.1997.7484","article-title":"Cloning and characterization of novel CIS family genes","volume":"239","author":"Masuhara","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib147","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1073\/pnas.95.1.114","article-title":"Twenty proteins containing a C-terminal SOCS box form five structural classes","volume":"95","author":"Hilton","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib148","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","article-title":"SOCS proteins: negative regulators of cytokine signaling","volume":"19","author":"Krebs","year":"2001","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbapap.2004.10.005_bib149","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1073\/pnas.95.24.14395","article-title":"Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1","volume":"95","author":"Starr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0092-8674(00)80049-5","article-title":"SOCS3 is essential in the regulation of fetal liver erythropoiesis","volume":"98","author":"Marine","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib151","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","article-title":"The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop","volume":"18","author":"Yasukawa","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib152","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1073\/pnas.95.26.15577","article-title":"Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice","volume":"95","author":"Naka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib153","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/emboj\/18.2.375","article-title":"Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction","volume":"18","author":"Nicholson","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib154","doi-asserted-by":"crossref","first-page":"13257","DOI":"10.1074\/jbc.M212026200","article-title":"Structural basis for dimerization of the Grb10 SH2 domain: implications for ligand specificity","volume":"278","author":"Stein","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(01)02282-7","article-title":"The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors","volume":"493","author":"Stein","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib156","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1074\/jbc.273.12.6860","volume":"273","author":"He","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib157","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","article-title":"Negative regulation of cytokine signaling pathways","volume":"18","author":"Yasukawa","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib158","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2004.10.005_bib159","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1128\/MCB.18.7.4109","article-title":"Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase","volume":"18","author":"Takahashi-Tezuka","year":"1998","journal-title":"Mol. Cell. Biol."},{"issue":"Pt 3","key":"10.1016\/j.bbapap.2004.10.005_bib160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/bj3350557","article-title":"Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression","volume":"335","author":"Schaper","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib161","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.4049\/jimmunol.165.5.2535","article-title":"Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation","volume":"165","author":"Anhuf","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib162","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1074-7613(00)80162-4","article-title":"Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses","volume":"12","author":"Ohtani","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bbapap.2004.10.005_bib163","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.20020619","article-title":"A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis","volume":"196","author":"Atsumi","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbapap.2004.10.005_bib164","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1073\/pnas.100135197","article-title":"Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130","volume":"97","author":"Nicholson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib165","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1021\/bi0259507","article-title":"SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities","volume":"41","author":"De Souza","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib166","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1074\/jbc.M210552200","article-title":"SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130","volume":"278","author":"Lehmann","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib167","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0169-328X(02)00452-7","article-title":"Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor","volume":"107","author":"Bartoe","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib168","doi-asserted-by":"crossref","first-page":"12848","DOI":"10.1074\/jbc.275.17.12848","article-title":"SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130","volume":"275","author":"Schmitz","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib169","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","article-title":"Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling","volume":"8","author":"Lu","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib171","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/35074525","article-title":"Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras","volume":"3","author":"Cacalano","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib172","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bj20030893","article-title":"The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling","volume":"378","author":"Fischer","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib173","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni938","article-title":"IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages","volume":"4","author":"Yasukawa","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib174","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib175","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.8388123","article-title":"New intracellular targets for therapeutic drug design","volume":"260","author":"Brugge","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib176","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2174\/0929867013371905","article-title":"Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70","volume":"8","author":"Garcia-Echeverria","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib177","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1535-7163.261.3.3","article-title":"Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity","volume":"3","author":"Turkson","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbapap.2004.10.005_bib178","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1021\/bi9814991","article-title":"Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide","volume":"37","author":"Bradshaw","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib179","doi-asserted-by":"crossref","first-page":"31711","DOI":"10.1016\/S0021-9258(18)31754-X","article-title":"Peptide inhibitors of src SH3-SH2-phosphoprotein interactions","volume":"269","author":"Gilmer","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib180","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2174\/1381612003398546","article-title":"Structure-based design of compounds inhibiting Grb2-SH2 mediated protein\u2013protein interactions in signal transduction pathways","volume":"6","author":"Fretz","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbapap.2004.10.005_bib181","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1367-5931(00)00222-2","article-title":"SH2 domain inhibition: a problem solved?","volume":"5","author":"Shakespeare","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib182","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1389557023405765","article-title":"SRC homology-2 inhibitors: peptidomimetic and nonpeptide","volume":"2","author":"Sawyer","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib183","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/bip.10600","article-title":"Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry","volume":"71","author":"Sundaramoorthi","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbapap.2004.10.005_bib184","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-642-80481-6_12","article-title":"Signaling through Grb2\/Ash-control of the Ras pathway and cytoskeleton","volume":"228","author":"Takenawa","year":"1998","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0092-8674(93)90146-H","article-title":"Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor","volume":"73","author":"Buday","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib186","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/363045a0","article-title":"Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation","volume":"363","author":"Egan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2004.10.005_bib187","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nsb0496-364","article-title":"Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes","volume":"3","author":"Nolte","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib188","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1021\/jm9702185","article-title":"Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain","volume":"40","author":"Furet","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib189","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/jm970856n","article-title":"Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2","volume":"41","author":"Garcia-Echeverria","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib190","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/S0960-894X(99)00501-6","article-title":"Mapping the X(+1) binding site of the Grb2-SH2 domain with alpha,alpha-disubstituted cyclic alpha-amino acids","volume":"9","author":"Garcia-Echeverria","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib191","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/jm991013u","article-title":"Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic","volume":"42","author":"Furet","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib192","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0960-894X(98)00701-X","article-title":"Highly potent inhibitors of the Grb2-SH2 domain","volume":"9","author":"Schoepfer","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib193","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B","article-title":"Selective GRB2 SH2 inhibitors as anti-Ras therapy","volume":"83","author":"Gay","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbapap.2004.10.005_bib194","doi-asserted-by":"crossref","first-page":"23311","DOI":"10.1074\/jbc.274.33.23311","article-title":"Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility","volume":"274","author":"Gay","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib195","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1021\/bi00156a002","article-title":"Inhibition of SH2 domain\/phosphoprotein association by a nonhydrolyzable phosphonopeptide","volume":"31","author":"Domchek","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib196","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1021\/ar020127o","article-title":"Phosphotyrosyl mimetics in the development of signal transduction inhibitors","volume":"36","author":"Burke","year":"2003","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib197","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1021\/bi00187a015","article-title":"Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors","volume":"33","author":"Burke","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib198","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/jm980388x","article-title":"Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands","volume":"42","author":"Yao","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib199","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-894X(98)00740-9","article-title":"Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors","volume":"9","author":"Burke","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/jm9904248","article-title":"Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic","volume":"43","author":"Gao","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib201","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0960-894X(01)00316-X","article-title":"Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor","volume":"11","author":"Gao","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/jm0203635","article-title":"Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems","volume":"46","author":"Wei","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib203","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/jm030510e","article-title":"Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands","volume":"47","author":"Shi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib204","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2003.09.029","article-title":"A novel macrocyclic tetrapeptide mimetic that exhibits low-picomolar Grb2 SH2 domain-binding affinity","volume":"310","author":"Shi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib205","doi-asserted-by":"crossref","first-page":"29046","DOI":"10.1074\/jbc.272.46.29046","article-title":"Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain","volume":"272","author":"Oligino","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib206","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1034\/j.1399-3011.2001.00833.x","article-title":"Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain","volume":"57","author":"Lung","year":"2001","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib207","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/abbi.1999.1513","article-title":"Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain","volume":"372","author":"Lou","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2004.10.005_bib208","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0960-894X(99)00379-0","article-title":"Significant compensatory role of position Y-2 conferring high affinity to non-phosphorylated inhibitors of Grb2-SH2 domain","volume":"9","author":"Long","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib209","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0006-291X(03)01291-9","article-title":"Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity","volume":"307","author":"Li","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib210","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1021\/ol035078+","article-title":"Concise and enantioselective synthesis of Fmoc-Pmp(Bu(t))(2)-OH and design of potent Pmp-containing Grb2-SH2 domain antagonists","volume":"5","author":"Li","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib211","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.bmcl.2004.03.103","article-title":"Development of l-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity","volume":"14","author":"Song","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib212","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1006\/jmbi.1998.1790","article-title":"Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands","volume":"279","author":"Rahuel","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib213","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0968-0896(01)00014-1","article-title":"N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding","volume":"9","author":"Burke","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib214","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1006\/bbrc.1997.6694","article-title":"An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain","volume":"234","author":"Rojas","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib215","first-page":"4773","article-title":"Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product","volume":"52","author":"Ottenhoff-Kalff","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib216","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0959-8049(05)80056-5","article-title":"Expression of pp60c-src in human small cell and non-small cell lung carcinomas","volume":"28","author":"Mazurenko","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbapap.2004.10.005_bib217","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI115956","article-title":"Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines","volume":"90","author":"Weber","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbapap.2004.10.005_bib218","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib219","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1101\/gad.11.21.2835","article-title":"Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src\u2212\/\u2212 mutant mice","volume":"11","author":"Schwartzberg","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbapap.2004.10.005_bib220","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0968-0896(99)00045-0","article-title":"Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis","volume":"7","author":"Gil","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib221","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1021\/jm970853a","article-title":"Potent dipeptide inhibitors of the pp60c-src SH2 domain","volume":"41","author":"Pacofsky","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib222","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/jm010927p","article-title":"SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2","volume":"45","author":"Lesuisse","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib223","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1006\/jmbi.1996.0112","article-title":"Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution","volume":"256","author":"Tong","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib224","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0960-894X(99)00388-1","article-title":"Structure-based design and synthesis of a novel class of Src SH2 inhibitors","volume":"9","author":"Buchanan","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1006\/jmbi.2000.3765","article-title":"Mutational investigation of the specificity determining region of the Src SH2 domain","volume":"299","author":"Bradshaw","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib226","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1021\/jm0003337","article-title":"Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domain","volume":"43","author":"Shakespeare","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib227","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1021\/jm970402q","article-title":"Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand","volume":"40","author":"Plummer","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib228","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0960-894X(99)00389-3","article-title":"Structure\u2013activity relationships of a novel class of Src SH2 inhibitors","volume":"9","author":"Buchanan","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib229","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1021\/ja971794t","article-title":"Structure-based design of a novel series of nonpeptide. Ligands that bind to the pp60src SH2 domain","volume":"119","author":"Lunney","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbapap.2004.10.005_bib230","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0960-894X(02)00139-7","article-title":"Discovery of highly potent Src SH2 binders: structure\u2013activity studies and X-ray structures","volume":"12","author":"Deprez","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib231","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1021\/bi970019n","article-title":"Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study","volume":"36","author":"Charifson","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib232","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0960-894X(98)00195-4","article-title":"The formation of a covalent complex between a dipeptide ligand and the src SH2 domain","volume":"8","author":"Alligood","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib233","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-5521(00)00090-9","article-title":"A Src SH2 selective binding compound inhibits osteoclast-mediated resorption","volume":"7","author":"Violette","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib234","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/S0960-894X(99)00545-4","article-title":"An efficient synthesis of a 4\u2032-phosphonodifluoromethyl-3\u2032-formyl-phenylalanine containing SRC SH2 ligand","volume":"9","author":"Shakespeare","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib235","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.1021\/bi00046a044","article-title":"Catalytic activity of the SH2 domain of human pp60c-src; evidence from NMR, mass spectrometry, site-directed mutagenesis and kinetic studies for an inherent phosphatase activity","volume":"34","author":"Boerner","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib236","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/jm0002681","article-title":"X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor","volume":"44","author":"Bohacek","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib237","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1073\/pnas.97.17.9373","article-title":"Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity","volume":"97","author":"Shakespeare","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib238","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S8756-3282(00)00427-0","article-title":"Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption","volume":"28","author":"Violette","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bbapap.2004.10.005_bib239","first-page":"3026","article-title":"Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate","volume":"63","author":"Sohara","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2004.10.005_bib240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00223-002-0025-x","article-title":"Bisphosphonate actions on cancer","volume":"73","author":"Yoneda","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bbapap.2004.10.005_bib241","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S8756-3282(99)00020-4","article-title":"A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo","volume":"24","author":"Missbach","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bbapap.2004.10.005_bib242","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/S0960-894X(03)00649-8","article-title":"Bone-Targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents","volume":"13","author":"Vu","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2004.10.005_bib243","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/jm0110800","article-title":"Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysis","volume":"45","author":"Lange","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib244","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0959-440X(96)80015-7","article-title":"Protein\u2013drug complexes important for immunoregulation and organ transplantation","volume":"6","author":"Navia","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF03190191","article-title":"Transport of peptide and protein drugs across biological membranes","volume":"15","author":"Verhoef","year":"1990","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bbapap.2004.10.005_bib246","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/jm980676t","article-title":"Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements","volume":"42","author":"Beaulieu","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib247","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1074-5521(98)90112-0","article-title":"A novel mechanism-based mammalian cell assay for the identification of SH2-domain-specific protein\u2013protein inhibitors","volume":"5","author":"Rickles","year":"1998","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbapap.2004.10.005_bib248","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1535-6108(02)00025-9","article-title":"Perspectives on the development of a molecularly targeted agent","volume":"1","author":"Druker","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib249","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2796.2003.01098.x","article-title":"Overview of the clinical efficacy of investigational anticancer drugs","volume":"253","author":"Nygren","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbapap.2004.10.005_bib250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-291X(02)02424-5","article-title":"High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system","volume":"298","author":"Mandine","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib251","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.97.6.2419","article-title":"Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors","volume":"97","author":"Maly","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib252","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1074\/jbc.M009262200","article-title":"Molecular rulers: an assessment of distance and spatial relationships of Src tyrosine kinase Sh2 and active site regions","volume":"276","author":"Profit","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib253","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/mcp.R300002-MCP200","article-title":"Profiling the global tyrosine phosphorylation state","volume":"2","author":"Machida","year":"2003","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.bbapap.2004.10.005_bib254","doi-asserted-by":"crossref","first-page":"13531","DOI":"10.1073\/pnas.241215998","article-title":"Profiling the global tyrosine phosphorylation state by src homology 2 domain binding","volume":"98","author":"Nollau","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2004.10.005_bib255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1242\/jcs.1994.Supplement_18.18","article-title":"Specificity in recognition of phosphopeptides by src-homology 2 domains","volume":"18","author":"Cantley","year":"1994","journal-title":"J. Cell Sci., Suppl."},{"key":"10.1016\/j.bbapap.2004.10.005_bib256","doi-asserted-by":"crossref","first-page":"16500","DOI":"10.1074\/jbc.271.28.16500","article-title":"Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting","volume":"271","author":"Muller","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib257","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1432-1033.1997.00633.x","article-title":"Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display","volume":"246","author":"Gram","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib258","doi-asserted-by":"crossref","first-page":"16117","DOI":"10.1074\/jbc.M300261200","article-title":"Characterization of phosphopeptide motifs specific for the Src homology 2 domains of signal transducer and activator of transcription 1 (STAT1) and STAT3","volume":"278","author":"Wiederkehr-Adam","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib259","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0092-8674(92)90444-H","article-title":"Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways","volume":"69","author":"Fantl","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2004.10.005_bib260","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/j.1460-2075.1992.tb05182.x","article-title":"Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo","volume":"11","author":"Kashishian","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2004.10.005_bib261","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1016\/S0021-9258(17)34083-8","article-title":"SH-PTP2\/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides","volume":"269","author":"Case","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib262","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1021\/bi00003a039","article-title":"Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2","volume":"34","author":"Huyer","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.10.005_bib263","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.7871433","article-title":"Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors","volume":"267","author":"Stahl","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2004.10.005_bib264","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1074\/jbc.271.22.12991","article-title":"Differential activation of acute phase response factor\/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation","volume":"271","author":"Gerhartz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.10.005_bib265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/bbrc.1995.1629","article-title":"EGF receptor deletions define a region specifically mediating STAT transcription factor activation","volume":"210","author":"Coffer","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.10.005_bib266","doi-asserted-by":"crossref","first-page":"18967","DOI":"10.1074\/jbc.M314037200","article-title":"Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif","volume":"279","author":"Shao","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963904002882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963904002882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T23:07:10Z","timestamp":1682809630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963904002882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":266,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1570963904002882"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2004.10.005","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}